ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
  • Category
  • Region
U.S. (TOLL FREE)
+1 (315) 215-3225
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Covid-19 Treatment Medicine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: June 2024
|
Report Code: QYRE-Auto-35D10498
Home | Market Reports | Health| Pharmacy
Global Covid 19 Treatment Medicine Market Research Report 2022
BUY CHAPTERS

Covid-19 Treatment Medicine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-35D10498
Report
June 2024
Pages:97
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
VEKLURY (Remdesivir)
Yiling Pharmaceutical
Pfizer (Paxlovid)
Lagevrio
GSK (Sotrovimab)
Regeneron (Ronapreve)

Covid-19 Treatment Medicine - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Covid-19 Treatment Medicine - Market

Covid-19 Treatment Medicine - Market

Covid-19 Treatment Medicines are medications use to treat COVID-19, including oral and Injetion Medicine.
The global market for Covid-19 Treatment Medicine was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Covid-19 Treatment Medicine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Covid-19 Treatment Medicine by region & country, by Type, and by Application.
The Covid-19 Treatment Medicine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Covid-19 Treatment Medicine.
Market Segmentation

Scope of Covid-19 Treatment Medicine - Market Report

Report Metric Details
Report Name Covid-19 Treatment Medicine - Market
CAGR 5%
Segment by Type:
  • Oral
  • Injetion
Segment by Application
  • Mild-to-Moderate COVID-19
  • Severe Patient
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer (Paxlovid), VEKLURY (Remdesivir), Lagevrio, GSK (Sotrovimab), Regeneron (Ronapreve), Yiling Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Covid-19 Treatment Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Covid-19 Treatment Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Covid-19 Treatment Medicine in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Covid-19 Treatment Medicine - Market report?

Ans: The main players in the Covid-19 Treatment Medicine - Market are Pfizer (Paxlovid), VEKLURY (Remdesivir), Lagevrio, GSK (Sotrovimab), Regeneron (Ronapreve), Yiling Pharmaceutical

What are the Application segmentation covered in the Covid-19 Treatment Medicine - Market report?

Ans: The Applications covered in the Covid-19 Treatment Medicine - Market report are Mild-to-Moderate COVID-19, Severe Patient

What are the Type segmentation covered in the Covid-19 Treatment Medicine - Market report?

Ans: The Types covered in the Covid-19 Treatment Medicine - Market report are Oral, Injetion

1 Market Overview
1.1 Covid-19 Treatment Medicine Product Introduction
1.2 Global Covid-19 Treatment Medicine Market Size Forecast
1.2.1 Global Covid-19 Treatment Medicine Sales Value (2019-2030)
1.2.2 Global Covid-19 Treatment Medicine Sales Volume (2019-2030)
1.2.3 Global Covid-19 Treatment Medicine Sales Price (2019-2030)
1.3 Covid-19 Treatment Medicine Market Trends & Drivers
1.3.1 Covid-19 Treatment Medicine Industry Trends
1.3.2 Covid-19 Treatment Medicine Market Drivers & Opportunity
1.3.3 Covid-19 Treatment Medicine Market Challenges
1.3.4 Covid-19 Treatment Medicine Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Covid-19 Treatment Medicine Players Revenue Ranking (2023)
2.2 Global Covid-19 Treatment Medicine Revenue by Company (2019-2024)
2.3 Global Covid-19 Treatment Medicine Players Sales Volume Ranking (2023)
2.4 Global Covid-19 Treatment Medicine Sales Volume by Company Players (2019-2024)
2.5 Global Covid-19 Treatment Medicine Average Price by Company (2019-2024)
2.6 Key Manufacturers Covid-19 Treatment Medicine Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Covid-19 Treatment Medicine Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Covid-19 Treatment Medicine
2.9 Covid-19 Treatment Medicine Market Competitive Analysis
2.9.1 Covid-19 Treatment Medicine Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Covid-19 Treatment Medicine Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Covid-19 Treatment Medicine as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Oral
3.1.2 Injetion
3.2 Global Covid-19 Treatment Medicine Sales Value by Type
3.2.1 Global Covid-19 Treatment Medicine Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Covid-19 Treatment Medicine Sales Value, by Type (2019-2030)
3.2.3 Global Covid-19 Treatment Medicine Sales Value, by Type (%) (2019-2030)
3.3 Global Covid-19 Treatment Medicine Sales Volume by Type
3.3.1 Global Covid-19 Treatment Medicine Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Covid-19 Treatment Medicine Sales Volume, by Type (2019-2030)
3.3.3 Global Covid-19 Treatment Medicine Sales Volume, by Type (%) (2019-2030)
3.4 Global Covid-19 Treatment Medicine Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Mild-to-Moderate COVID-19
4.1.2 Severe Patient
4.2 Global Covid-19 Treatment Medicine Sales Value by Application
4.2.1 Global Covid-19 Treatment Medicine Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Covid-19 Treatment Medicine Sales Value, by Application (2019-2030)
4.2.3 Global Covid-19 Treatment Medicine Sales Value, by Application (%) (2019-2030)
4.3 Global Covid-19 Treatment Medicine Sales Volume by Application
4.3.1 Global Covid-19 Treatment Medicine Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Covid-19 Treatment Medicine Sales Volume, by Application (2019-2030)
4.3.3 Global Covid-19 Treatment Medicine Sales Volume, by Application (%) (2019-2030)
4.4 Global Covid-19 Treatment Medicine Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Covid-19 Treatment Medicine Sales Value by Region
5.1.1 Global Covid-19 Treatment Medicine Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Covid-19 Treatment Medicine Sales Value by Region (2019-2024)
5.1.3 Global Covid-19 Treatment Medicine Sales Value by Region (2025-2030)
5.1.4 Global Covid-19 Treatment Medicine Sales Value by Region (%), (2019-2030)
5.2 Global Covid-19 Treatment Medicine Sales Volume by Region
5.2.1 Global Covid-19 Treatment Medicine Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Covid-19 Treatment Medicine Sales Volume by Region (2019-2024)
5.2.3 Global Covid-19 Treatment Medicine Sales Volume by Region (2025-2030)
5.2.4 Global Covid-19 Treatment Medicine Sales Volume by Region (%), (2019-2030)
5.3 Global Covid-19 Treatment Medicine Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Covid-19 Treatment Medicine Sales Value, 2019-2030
5.4.2 North America Covid-19 Treatment Medicine Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Covid-19 Treatment Medicine Sales Value, 2019-2030
5.5.2 Europe Covid-19 Treatment Medicine Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Covid-19 Treatment Medicine Sales Value, 2019-2030
5.6.2 Asia Pacific Covid-19 Treatment Medicine Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Covid-19 Treatment Medicine Sales Value, 2019-2030
5.7.2 South America Covid-19 Treatment Medicine Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Covid-19 Treatment Medicine Sales Value, 2019-2030
5.8.2 Middle East & Africa Covid-19 Treatment Medicine Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Covid-19 Treatment Medicine Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Covid-19 Treatment Medicine Sales Value
6.2.1 Key Countries/Regions Covid-19 Treatment Medicine Sales Value, 2019-2030
6.2.2 Key Countries/Regions Covid-19 Treatment Medicine Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Covid-19 Treatment Medicine Sales Value, 2019-2030
6.3.2 United States Covid-19 Treatment Medicine Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Covid-19 Treatment Medicine Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Covid-19 Treatment Medicine Sales Value, 2019-2030
6.4.2 Europe Covid-19 Treatment Medicine Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Covid-19 Treatment Medicine Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Covid-19 Treatment Medicine Sales Value, 2019-2030
6.5.2 China Covid-19 Treatment Medicine Sales Value by Type (%), 2023 VS 2030
6.5.3 China Covid-19 Treatment Medicine Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Covid-19 Treatment Medicine Sales Value, 2019-2030
6.6.2 Japan Covid-19 Treatment Medicine Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Covid-19 Treatment Medicine Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Covid-19 Treatment Medicine Sales Value, 2019-2030
6.7.2 South Korea Covid-19 Treatment Medicine Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Covid-19 Treatment Medicine Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Covid-19 Treatment Medicine Sales Value, 2019-2030
6.8.2 Southeast Asia Covid-19 Treatment Medicine Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Covid-19 Treatment Medicine Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Covid-19 Treatment Medicine Sales Value, 2019-2030
6.9.2 India Covid-19 Treatment Medicine Sales Value by Type (%), 2023 VS 2030
6.9.3 India Covid-19 Treatment Medicine Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Pfizer (Paxlovid)
7.1.1 Pfizer (Paxlovid) Company Information
7.1.2 Pfizer (Paxlovid) Introduction and Business Overview
7.1.3 Pfizer (Paxlovid) Covid-19 Treatment Medicine Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Pfizer (Paxlovid) Covid-19 Treatment Medicine Product Offerings
7.1.5 Pfizer (Paxlovid) Recent Development
7.2 VEKLURY (Remdesivir)
7.2.1 VEKLURY (Remdesivir) Company Information
7.2.2 VEKLURY (Remdesivir) Introduction and Business Overview
7.2.3 VEKLURY (Remdesivir) Covid-19 Treatment Medicine Sales, Revenue and Gross Margin (2019-2024)
7.2.4 VEKLURY (Remdesivir) Covid-19 Treatment Medicine Product Offerings
7.2.5 VEKLURY (Remdesivir) Recent Development
7.3 Lagevrio
7.3.1 Lagevrio Company Information
7.3.2 Lagevrio Introduction and Business Overview
7.3.3 Lagevrio Covid-19 Treatment Medicine Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Lagevrio Covid-19 Treatment Medicine Product Offerings
7.3.5 Lagevrio Recent Development
7.4 GSK (Sotrovimab)
7.4.1 GSK (Sotrovimab) Company Information
7.4.2 GSK (Sotrovimab) Introduction and Business Overview
7.4.3 GSK (Sotrovimab) Covid-19 Treatment Medicine Sales, Revenue and Gross Margin (2019-2024)
7.4.4 GSK (Sotrovimab) Covid-19 Treatment Medicine Product Offerings
7.4.5 GSK (Sotrovimab) Recent Development
7.5 Regeneron (Ronapreve)
7.5.1 Regeneron (Ronapreve) Company Information
7.5.2 Regeneron (Ronapreve) Introduction and Business Overview
7.5.3 Regeneron (Ronapreve) Covid-19 Treatment Medicine Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Regeneron (Ronapreve) Covid-19 Treatment Medicine Product Offerings
7.5.5 Regeneron (Ronapreve) Recent Development
7.6 Yiling Pharmaceutical
7.6.1 Yiling Pharmaceutical Company Information
7.6.2 Yiling Pharmaceutical Introduction and Business Overview
7.6.3 Yiling Pharmaceutical Covid-19 Treatment Medicine Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Yiling Pharmaceutical Covid-19 Treatment Medicine Product Offerings
7.6.5 Yiling Pharmaceutical Recent Development
8 Industry Chain Analysis
8.1 Covid-19 Treatment Medicine Industrial Chain
8.2 Covid-19 Treatment Medicine Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Covid-19 Treatment Medicine Sales Model
8.5.2 Sales Channel
8.5.3 Covid-19 Treatment Medicine Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
FEATURED COMPANIES
VEKLURY (Remdesivir)
Yiling Pharmaceutical
Pfizer (Paxlovid)
Lagevrio
GSK (Sotrovimab)
Regeneron (Ronapreve)
List of Tables
    Table 1. Covid-19 Treatment Medicine Market Trends
    Table 2. Covid-19 Treatment Medicine Market Drivers & Opportunity
    Table 3. Covid-19 Treatment Medicine Market Challenges
    Table 4. Covid-19 Treatment Medicine Market Restraints
    Table 5. Global Covid-19 Treatment Medicine Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Covid-19 Treatment Medicine Revenue Market Share by Company (2019-2024)
    Table 7. Global Covid-19 Treatment Medicine Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Covid-19 Treatment Medicine Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Covid-19 Treatment Medicine Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Covid-19 Treatment Medicine Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Covid-19 Treatment Medicine Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Covid-19 Treatment Medicine
    Table 13. Global Covid-19 Treatment Medicine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Covid-19 Treatment Medicine as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Covid-19 Treatment Medicine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Covid-19 Treatment Medicine Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Covid-19 Treatment Medicine Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Covid-19 Treatment Medicine Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Covid-19 Treatment Medicine Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Covid-19 Treatment Medicine Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Covid-19 Treatment Medicine Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Covid-19 Treatment Medicine Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Covid-19 Treatment Medicine Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Covid-19 Treatment Medicine Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Covid-19 Treatment Medicine Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Covid-19 Treatment Medicine Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Covid-19 Treatment Medicine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Covid-19 Treatment Medicine Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Covid-19 Treatment Medicine Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Covid-19 Treatment Medicine Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Covid-19 Treatment Medicine Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Covid-19 Treatment Medicine Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Covid-19 Treatment Medicine Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Covid-19 Treatment Medicine Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Covid-19 Treatment Medicine Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Covid-19 Treatment Medicine Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Covid-19 Treatment Medicine Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Covid-19 Treatment Medicine Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Covid-19 Treatment Medicine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Covid-19 Treatment Medicine Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Covid-19 Treatment Medicine Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Covid-19 Treatment Medicine Sales Value by Region (2019-2024) & (%)
    Table 44. Global Covid-19 Treatment Medicine Sales Value by Region (2025-2030) & (%)
    Table 45. Global Covid-19 Treatment Medicine Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Covid-19 Treatment Medicine Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Covid-19 Treatment Medicine Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Covid-19 Treatment Medicine Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Covid-19 Treatment Medicine Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Covid-19 Treatment Medicine Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Covid-19 Treatment Medicine Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Covid-19 Treatment Medicine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Covid-19 Treatment Medicine Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Covid-19 Treatment Medicine Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Covid-19 Treatment Medicine Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Covid-19 Treatment Medicine Sales Volume, (2025-2030) & (K Units)
    Table 57. Pfizer (Paxlovid) Company Information
    Table 58. Pfizer (Paxlovid) Introduction and Business Overview
    Table 59. Pfizer (Paxlovid) Covid-19 Treatment Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Pfizer (Paxlovid) Covid-19 Treatment Medicine Product Offerings
    Table 61. Pfizer (Paxlovid) Recent Development
    Table 62. VEKLURY (Remdesivir) Company Information
    Table 63. VEKLURY (Remdesivir) Introduction and Business Overview
    Table 64. VEKLURY (Remdesivir) Covid-19 Treatment Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. VEKLURY (Remdesivir) Covid-19 Treatment Medicine Product Offerings
    Table 66. VEKLURY (Remdesivir) Recent Development
    Table 67. Lagevrio Company Information
    Table 68. Lagevrio Introduction and Business Overview
    Table 69. Lagevrio Covid-19 Treatment Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Lagevrio Covid-19 Treatment Medicine Product Offerings
    Table 71. Lagevrio Recent Development
    Table 72. GSK (Sotrovimab) Company Information
    Table 73. GSK (Sotrovimab) Introduction and Business Overview
    Table 74. GSK (Sotrovimab) Covid-19 Treatment Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. GSK (Sotrovimab) Covid-19 Treatment Medicine Product Offerings
    Table 76. GSK (Sotrovimab) Recent Development
    Table 77. Regeneron (Ronapreve) Company Information
    Table 78. Regeneron (Ronapreve) Introduction and Business Overview
    Table 79. Regeneron (Ronapreve) Covid-19 Treatment Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Regeneron (Ronapreve) Covid-19 Treatment Medicine Product Offerings
    Table 81. Regeneron (Ronapreve) Recent Development
    Table 82. Yiling Pharmaceutical Company Information
    Table 83. Yiling Pharmaceutical Introduction and Business Overview
    Table 84. Yiling Pharmaceutical Covid-19 Treatment Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. Yiling Pharmaceutical Covid-19 Treatment Medicine Product Offerings
    Table 86. Yiling Pharmaceutical Recent Development
    Table 87. Key Raw Materials Lists
    Table 88. Raw Materials Key Suppliers Lists
    Table 89. Covid-19 Treatment Medicine Downstream Customers
    Table 90. Covid-19 Treatment Medicine Distributors List
    Table 91. Research Programs/Design for This Report
    Table 92. Key Data Information from Secondary Sources
    Table 93. Key Data Information from Primary Sources
List of Figures
    Figure 1. Covid-19 Treatment Medicine Product Picture
    Figure 2. Global Covid-19 Treatment Medicine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Covid-19 Treatment Medicine Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Covid-19 Treatment Medicine Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Covid-19 Treatment Medicine Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Covid-19 Treatment Medicine Report Years Considered
    Figure 7. Global Covid-19 Treatment Medicine Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Covid-19 Treatment Medicine Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Covid-19 Treatment Medicine Revenue in 2023
    Figure 10. Covid-19 Treatment Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Oral Picture
    Figure 12. Injetion Picture
    Figure 13. Global Covid-19 Treatment Medicine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Covid-19 Treatment Medicine Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Covid-19 Treatment Medicine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 16. Global Covid-19 Treatment Medicine Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Covid-19 Treatment Medicine Price by Type (2019-2030) & (US$/Unit)
    Figure 18. Product Picture of Mild-to-Moderate COVID-19
    Figure 19. Product Picture of Severe Patient
    Figure 20. Global Covid-19 Treatment Medicine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 21. Global Covid-19 Treatment Medicine Sales Value Market Share by Application, 2023 & 2030
    Figure 22. Global Covid-19 Treatment Medicine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 23. Global Covid-19 Treatment Medicine Sales Volume Market Share by Application, 2023 & 2030
    Figure 24. Global Covid-19 Treatment Medicine Price by Application (2019-2030) & (US$/Unit)
    Figure 25. North America Covid-19 Treatment Medicine Sales Value (2019-2030) & (US$ Million)
    Figure 26. North America Covid-19 Treatment Medicine Sales Value by Country (%), 2023 VS 2030
    Figure 27. Europe Covid-19 Treatment Medicine Sales Value (2019-2030) & (US$ Million)
    Figure 28. Europe Covid-19 Treatment Medicine Sales Value by Country (%), 2023 VS 2030
    Figure 29. Asia Pacific Covid-19 Treatment Medicine Sales Value (2019-2030) & (US$ Million)
    Figure 30. Asia Pacific Covid-19 Treatment Medicine Sales Value by Country (%), 2023 VS 2030
    Figure 31. South America Covid-19 Treatment Medicine Sales Value (2019-2030) & (US$ Million)
    Figure 32. South America Covid-19 Treatment Medicine Sales Value by Country (%), 2023 VS 2030
    Figure 33. Middle East & Africa Covid-19 Treatment Medicine Sales Value (2019-2030) & (US$ Million)
    Figure 34. Middle East & Africa Covid-19 Treatment Medicine Sales Value by Country (%), 2023 VS 2030
    Figure 35. Key Countries/Regions Covid-19 Treatment Medicine Sales Value (%), (2019-2030)
    Figure 36. Key Countries/Regions Covid-19 Treatment Medicine Sales Volume (%), (2019-2030)
    Figure 37. United States Covid-19 Treatment Medicine Sales Value, (2019-2030) & (US$ Million)
    Figure 38. United States Covid-19 Treatment Medicine Sales Value by Type (%), 2023 VS 2030
    Figure 39. United States Covid-19 Treatment Medicine Sales Value by Application (%), 2023 VS 2030
    Figure 40. Europe Covid-19 Treatment Medicine Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Europe Covid-19 Treatment Medicine Sales Value by Type (%), 2023 VS 2030
    Figure 42. Europe Covid-19 Treatment Medicine Sales Value by Application (%), 2023 VS 2030
    Figure 43. China Covid-19 Treatment Medicine Sales Value, (2019-2030) & (US$ Million)
    Figure 44. China Covid-19 Treatment Medicine Sales Value by Type (%), 2023 VS 2030
    Figure 45. China Covid-19 Treatment Medicine Sales Value by Application (%), 2023 VS 2030
    Figure 46. Japan Covid-19 Treatment Medicine Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Japan Covid-19 Treatment Medicine Sales Value by Type (%), 2023 VS 2030
    Figure 48. Japan Covid-19 Treatment Medicine Sales Value by Application (%), 2023 VS 2030
    Figure 49. South Korea Covid-19 Treatment Medicine Sales Value, (2019-2030) & (US$ Million)
    Figure 50. South Korea Covid-19 Treatment Medicine Sales Value by Type (%), 2023 VS 2030
    Figure 51. South Korea Covid-19 Treatment Medicine Sales Value by Application (%), 2023 VS 2030
    Figure 52. Southeast Asia Covid-19 Treatment Medicine Sales Value, (2019-2030) & (US$ Million)
    Figure 53. Southeast Asia Covid-19 Treatment Medicine Sales Value by Type (%), 2023 VS 2030
    Figure 54. Southeast Asia Covid-19 Treatment Medicine Sales Value by Application (%), 2023 VS 2030
    Figure 55. India Covid-19 Treatment Medicine Sales Value, (2019-2030) & (US$ Million)
    Figure 56. India Covid-19 Treatment Medicine Sales Value by Type (%), 2023 VS 2030
    Figure 57. India Covid-19 Treatment Medicine Sales Value by Application (%), 2023 VS 2030
    Figure 58. Covid-19 Treatment Medicine Industrial Chain
    Figure 59. Covid-19 Treatment Medicine Manufacturing Cost Structure
    Figure 60. Channels of Distribution (Direct Sales, and Distribution)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Ibuprofen Sodium​ API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30X13296
Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Enteric Gelatin Hollow Capsule Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-11U13426
Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Argatroban Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

120 Pages
Type: Report
Code: QYRE-Auto-16160
Fri Mar 21 00:00:00 UTC 2025

$8000

Enterprise User

Add to Cart

Global Contrast Agents Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

120 Pages
Type: Report
Code: QYRE-Auto-10G2665
Fri Mar 21 00:00:00 UTC 2025

$8000

Enterprise User

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions